Therapeutic Apheresis & Cellular Therapy
During plasma exchange therapy, a patient’s plasma is removed and replaced with 5% albumin, saline and/or donated plasma. TPE is used for a wide range of indications, including TTP, antibody-mediated syndromes in neurology, nephrology and hematology, and organ transplantation.
Performed at:
- Versiti Blood Center of Wisconsin
- Versiti Blood Center of Michigan
A procedure in which abnormal red blood cells (RBCs) are removed and replaced with donated RBCs. RBCX is performed for acute episodes and chronic management in sickle cell disease and in the case of certain infections (e.g., malaria and babesiosis) in which RBCs are damaged.
Performed at:
- Versiti Blood Center of Wisconsin
- Versiti Blood Center of Michigan
During this procedure, an excessive amount of white blood cells is rapidly removed in disease causing hyperleukocytosis, such as leukemia, which may cause complications such as stroke, respiratory failure and/or renal failure.
Performed at:
- Versiti Blood Center of Wisconsin
- Versiti Blood Center of Michigan
A procedure in which an excessive amount of platelets is rapidly removed in diseases like essential thrombocytosis, which may cause complications, such as stroke or heart attack.
Performed at:
- Versiti Blood Center of Wisconsin
- Versiti Blood Center of Michigan
A procedure in which white blood cells are separated from a patient’s blood and treated with a medication called Methoxsalen, which makes them sensitive to ultraviolet light. The treated white blood cells are exposed to ultraviolet light and returned to the patient. Photopheresis may be used to treat graft vs. host disease, cutaneous T-cell lymphoma and organ transplant rejection.
Performed at:
- Versiti Blood Center of Wisconsin
- Versiti Blood Center of Michigan
A procedure in which LDL cholesterol is rapidly removed for chronic treatment of hypercholesterolemia.
Performed at:
- Versiti Blood Center of Wisconsin
A procedure in which MNCs (lymphocytes and monocytes) are removed from an autologous or allogenic donor. For autologous collections, the cells may be engineered (per independent lab protocols) to develop an individualized cancer treatment.
- MNC collections for dendreon for development of provenge (sipuleucel-T) for treatment of prostate cancer
- MNC collections for novel cell therapies
BMT Requests:
- BMT Infusion Request
- PBSC Lymphocyte Collection and Processing Order
- Statement of Donor Eligibility
- Statement of Urgent Medical Need Ineligible Donor
- Statement of Urgent Medical Need Nonconforming Test Results
- Infectious Disease Marker (IDM) Testing
- Order to Release Cryopreserved Products – Fillable
- Post Collection Amendment of Eligibility
- Statement of Urgent Medical Need Donor with Incomplete Eligibility Determination
- Imported Product Request Order
- Outpatient BMT PBSC Orders
- Unpacking and Storing CBU at Hospital